Some scholars supported the idea that the symptoms and subtypes of depression influence IL-6 levels and suggested that using other depression-related cytokines or their receptors as biomarkers may help to classify MDD biological subtypes (49, 50). Here, IL6 is linked to depressive symptom measurement.